Cargando…

Angiolytic laser stripping versus CO2 laser microflap excision for vocal fold leukoplakia: Long-term disease control and voice outcomes

BACKGROUND AND PURPOSE: Vocal fold leukoplakia, white plaque on the epithelium, has the potential for malignant transformation regardless of dysplasia grade. It is treated with different laser types (CO(2) or angiolytic) and various techniques (vaporization, stripping, or excision); however, only a...

Descripción completa

Detalles Bibliográficos
Autores principales: Lim, Jae-Yol, Park, Young Min, Kang, Minsuk, Lee, Seung Jin, Baek, Kwangha, Na, Jina, Choi, Hong-Shik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6312374/
https://www.ncbi.nlm.nih.gov/pubmed/30596718
http://dx.doi.org/10.1371/journal.pone.0209691
_version_ 1783383773545496576
author Lim, Jae-Yol
Park, Young Min
Kang, Minsuk
Lee, Seung Jin
Baek, Kwangha
Na, Jina
Choi, Hong-Shik
author_facet Lim, Jae-Yol
Park, Young Min
Kang, Minsuk
Lee, Seung Jin
Baek, Kwangha
Na, Jina
Choi, Hong-Shik
author_sort Lim, Jae-Yol
collection PubMed
description BACKGROUND AND PURPOSE: Vocal fold leukoplakia, white plaque on the epithelium, has the potential for malignant transformation regardless of dysplasia grade. It is treated with different laser types (CO(2) or angiolytic) and various techniques (vaporization, stripping, or excision); however, only a few studies exist regarding comparative laser surgery results. This study was conducted to investigate clinical outcomes of CO(2) versus angiolytic laser microdissection with regard to long-term disease control and voice preservation in vocal fold leukoplakia. MATERIALS AND METHODS: Seventy patients with vocal fold leukoplakia treated by CO(2) or angiolytic laser (pulsed dye laser or potassium titanyl phosphate) were identified retrospectively. Data regarding patient characteristics, treatment details, treatment outcomes including disease control (recurrence and progression) and the Voice Handicap Index, GRBAS scale, and acoustics were evaluated. The mean follow-up duration after initial treatment was 32 ± 26 months. RESULTS: The study group comprised 14 patients who underwent CO(2) laser microflap excision and 56 who underwent angiolytic laser stripping. Of the patients treated with CO(2) laser, 11 (79%) had no recurrence and three (21%) showed recurrent leukoplakia, of which one patient (7%) showed histologic grade progression. Of patients who underwent angiolytic laser stripping, 12 had disease recurrence (21%), among whom three (5%) showed disease progression. Laser surgery type, disease extent, and histologic grade showed no significant differences in recurrence or progression rates. The postoperative Voice Handicap Index significantly improved (P = .03) and the G score significantly decreased (P < .001) in the angiolytic laser treatment group. In contrast, the Voice Handicap Index increased postoperatively in the CO(2) laser group (P = .046). CONCLUSIONS: The long-term recurrence or progression rates were not significantly different between angiolytic and CO(2) laser treatment. The angiolytic laser stripping group showed better voice preservation compared with the CO(2) laser group. Angiolytic laser stripping is suggested as an effective treatment option for vocal fold leukoplakia with comparable disease control and better voice preservation.
format Online
Article
Text
id pubmed-6312374
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-63123742019-01-08 Angiolytic laser stripping versus CO2 laser microflap excision for vocal fold leukoplakia: Long-term disease control and voice outcomes Lim, Jae-Yol Park, Young Min Kang, Minsuk Lee, Seung Jin Baek, Kwangha Na, Jina Choi, Hong-Shik PLoS One Research Article BACKGROUND AND PURPOSE: Vocal fold leukoplakia, white plaque on the epithelium, has the potential for malignant transformation regardless of dysplasia grade. It is treated with different laser types (CO(2) or angiolytic) and various techniques (vaporization, stripping, or excision); however, only a few studies exist regarding comparative laser surgery results. This study was conducted to investigate clinical outcomes of CO(2) versus angiolytic laser microdissection with regard to long-term disease control and voice preservation in vocal fold leukoplakia. MATERIALS AND METHODS: Seventy patients with vocal fold leukoplakia treated by CO(2) or angiolytic laser (pulsed dye laser or potassium titanyl phosphate) were identified retrospectively. Data regarding patient characteristics, treatment details, treatment outcomes including disease control (recurrence and progression) and the Voice Handicap Index, GRBAS scale, and acoustics were evaluated. The mean follow-up duration after initial treatment was 32 ± 26 months. RESULTS: The study group comprised 14 patients who underwent CO(2) laser microflap excision and 56 who underwent angiolytic laser stripping. Of the patients treated with CO(2) laser, 11 (79%) had no recurrence and three (21%) showed recurrent leukoplakia, of which one patient (7%) showed histologic grade progression. Of patients who underwent angiolytic laser stripping, 12 had disease recurrence (21%), among whom three (5%) showed disease progression. Laser surgery type, disease extent, and histologic grade showed no significant differences in recurrence or progression rates. The postoperative Voice Handicap Index significantly improved (P = .03) and the G score significantly decreased (P < .001) in the angiolytic laser treatment group. In contrast, the Voice Handicap Index increased postoperatively in the CO(2) laser group (P = .046). CONCLUSIONS: The long-term recurrence or progression rates were not significantly different between angiolytic and CO(2) laser treatment. The angiolytic laser stripping group showed better voice preservation compared with the CO(2) laser group. Angiolytic laser stripping is suggested as an effective treatment option for vocal fold leukoplakia with comparable disease control and better voice preservation. Public Library of Science 2018-12-31 /pmc/articles/PMC6312374/ /pubmed/30596718 http://dx.doi.org/10.1371/journal.pone.0209691 Text en © 2018 Lim et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Lim, Jae-Yol
Park, Young Min
Kang, Minsuk
Lee, Seung Jin
Baek, Kwangha
Na, Jina
Choi, Hong-Shik
Angiolytic laser stripping versus CO2 laser microflap excision for vocal fold leukoplakia: Long-term disease control and voice outcomes
title Angiolytic laser stripping versus CO2 laser microflap excision for vocal fold leukoplakia: Long-term disease control and voice outcomes
title_full Angiolytic laser stripping versus CO2 laser microflap excision for vocal fold leukoplakia: Long-term disease control and voice outcomes
title_fullStr Angiolytic laser stripping versus CO2 laser microflap excision for vocal fold leukoplakia: Long-term disease control and voice outcomes
title_full_unstemmed Angiolytic laser stripping versus CO2 laser microflap excision for vocal fold leukoplakia: Long-term disease control and voice outcomes
title_short Angiolytic laser stripping versus CO2 laser microflap excision for vocal fold leukoplakia: Long-term disease control and voice outcomes
title_sort angiolytic laser stripping versus co2 laser microflap excision for vocal fold leukoplakia: long-term disease control and voice outcomes
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6312374/
https://www.ncbi.nlm.nih.gov/pubmed/30596718
http://dx.doi.org/10.1371/journal.pone.0209691
work_keys_str_mv AT limjaeyol angiolyticlaserstrippingversusco2lasermicroflapexcisionforvocalfoldleukoplakialongtermdiseasecontrolandvoiceoutcomes
AT parkyoungmin angiolyticlaserstrippingversusco2lasermicroflapexcisionforvocalfoldleukoplakialongtermdiseasecontrolandvoiceoutcomes
AT kangminsuk angiolyticlaserstrippingversusco2lasermicroflapexcisionforvocalfoldleukoplakialongtermdiseasecontrolandvoiceoutcomes
AT leeseungjin angiolyticlaserstrippingversusco2lasermicroflapexcisionforvocalfoldleukoplakialongtermdiseasecontrolandvoiceoutcomes
AT baekkwangha angiolyticlaserstrippingversusco2lasermicroflapexcisionforvocalfoldleukoplakialongtermdiseasecontrolandvoiceoutcomes
AT najina angiolyticlaserstrippingversusco2lasermicroflapexcisionforvocalfoldleukoplakialongtermdiseasecontrolandvoiceoutcomes
AT choihongshik angiolyticlaserstrippingversusco2lasermicroflapexcisionforvocalfoldleukoplakialongtermdiseasecontrolandvoiceoutcomes